These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 26081027)
21. Marked Reduction of Pulmonary Artery Pressure After Registration for Lung Transplantation Is Associated With Long-Term Survival in Patients With Pulmonary Arterial Hypertension - Cohort Study. Akagi S; Matsubara H; Nakamura K; Oto T; Ejiri K; Ito H Circ J; 2020 Jan; 84(2):245-251. PubMed ID: 31866634 [TBL] [Abstract][Full Text] [Related]
22. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients. Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897 [TBL] [Abstract][Full Text] [Related]
23. Oral treprostinil diethanolamine for pulmonary arterial hypertension. Feldman J; Im Y; Gill K Expert Rev Clin Pharmacol; 2015 Jan; 8(1):55-60. PubMed ID: 25409915 [TBL] [Abstract][Full Text] [Related]
24. An evidence-based approach to the management of pulmonary arterial hypertension. Archer SL; Michelakis ED Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209 [TBL] [Abstract][Full Text] [Related]
25. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098 [TBL] [Abstract][Full Text] [Related]
28. Prostacyclin therapy for pulmonary arterial hypertension: new directions. Gomberg-Maitland M; Preston IR Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316 [TBL] [Abstract][Full Text] [Related]
29. Successful Liver Transplant Complicated by Severe Portopulmonary Hypertension After an Initial Aborted Attempt: Case Report and Review of Treatment Options. Reid K; McQuillan P; Kadry Z; Janicki P; Bezinover D Exp Clin Transplant; 2017 Jun; 15(3):361-365. PubMed ID: 26101938 [TBL] [Abstract][Full Text] [Related]
30. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan. Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673 [TBL] [Abstract][Full Text] [Related]
31. Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation. Vionnet J; Yerly P; Aubert JD; Pascual M; Aldenkortt F; Berney T; Giostra E; Moradpour D; Schiffer E Transplantation; 2018 May; 102(5):e194. PubMed ID: 29485510 [No Abstract] [Full Text] [Related]
38. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial. Jing ZC; Parikh K; Pulido T; Jerjes-Sanchez C; White RJ; Allen R; Torbicki A; Xu KF; Yehle D; Laliberte K; Arneson C; Rubin LJ Circulation; 2013 Feb; 127(5):624-33. PubMed ID: 23307827 [TBL] [Abstract][Full Text] [Related]
39. Treprostinil for the treatment of pulmonary arterial hypertension. Torres F; Rubin LJ Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441 [TBL] [Abstract][Full Text] [Related]
40. Right but not left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension. Toyooka S; Kusano KF; Goto K; Masaomi Y; Oto T; Sano Y; Fuke S; Okazaki M; Ohe T; Kasahara S; Sano S; Date H J Thorac Cardiovasc Surg; 2009 Jul; 138(1):222-6. PubMed ID: 19577083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]